what are the treatment options for anemia in non-del(5q) low-risk mds patients?
Published 6 years ago • 80 plays • Length 3:48Download video MP4
Download video MP3
Similar videos
-
11:33
treatment algorithm for low-risk mds
-
2:27
what are the treatment options for mds-related anemia?
-
6:36
mds: low-risk disease treatment options
-
6:31
choosing lenalidomide vs esas in del 5q mds
-
11:53
the optimal treatment of lower risk mds
-
5:56
transfusion-dependant, low-risk mds: what are the options?
-
25:10
management of lower-risk mds without del5q and refractory to esas
-
25:30
when is treatment needed for myelodysplastic syndrome (mds)?
-
4:21
when to use lenalidomide in mds patients with and without deletion 5q
-
1:43
reasons why there are fewer treatment options for mds patients and hope for the future
-
32:13
precision care for myelodysplastic syndromes
-
2:58
can patients with low-risk mds develop into a patient with high-risk disease?
-
7:25
what are the educational gaps in the diagnosis and treatment of mds?
-
3:46
current and emerging treatment options for lr-mds-associated anemia following esa failure
-
1:08
what are the goals of treatment for mds-related anemia?
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
1:39
what is the prognosis for mds-related anemia? how is prognosis determined?
-
47:38
understanding lower risk mds what are my options
-
26:05
options for treatment of mds